ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,375Medicare Part D Prescriptions Filled, Including Refills

Rank: 71 out of 617

$488K Total Retail Price of All Prescriptions

Rank: 108 out of 617

524 Patients Receiving at Least One Drug in Part D
87%Patients 65 Years and Older
38% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Nebraska
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 524 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

13% of this provider’s 524 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

2% of this provider’s 9,861 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$43 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Nebraska
OMEPRAZOLE 549 494 1 3
LEVOTHYROXINE SODIUM 521 413 2 1
FUROSEMIDE 369 329 3 4
SIMVASTATIN 349 320 4 2
AMLODIPINE BESYLATE 329 317 5 6
METOPROLOL TARTRATE 328 312 6 11
PRAVASTATIN SODIUM 278 263 7 21
HYDROCODONE-ACETAMINOPHEN 276 233 S3 8 8
LISINOPRIL 258 210 9 5
METFORMIN HCL 221 152 10 9
POTASSIUM CHLORIDE 217 193 11 10
WARFARIN SODIUM 202 166 12 7
HYDROCHLOROTHIAZIDE 191 186 13 13
SERTRALINE HCL 189 140 14 20
TRAMADOL HCL 169 124 15 15
PREDNISONE 164 146 16 31
RANITIDINE HCL 157 133 17 40
DIGOXIN 151 138 18 48
CITALOPRAM HBR 142 132 19 18
LOSARTAN POTASSIUM 140 115 20 22
CARVEDILOL 140 121 20 19
GABAPENTIN 135 99 22 16
SPIRONOLACTONE 126 112 23 42
GLIPIZIDE 124 124 24 82
METOPROLOL SUCCINATE 117 108 25 12
ADVAIR DISKUS 114 98 26 38
NAMENDA 113 113 27 35
LOSARTAN-HYDROCHLOROTHIAZIDE 112 112 28 46
LISINOPRIL-HYDROCHLOROTHIAZIDE 110 107 29 29
ATORVASTATIN CALCIUM 107 100 30 14
DILTIAZEM 24HR CD 102 97 31 117
ATENOLOL 102 97 31 17
CRESTOR 101 101 33 28
ALLOPURINOL 94 82 34 27
DIOVAN 84 84 35 41
TAMSULOSIN HCL 83 83 36 26
TRIAMTERENE-HCTZ 82 75 37 47
GLYBURIDE 79 61 R 38 84
VERAPAMIL ER 78 75 39 90
LANTUS 77 69 40 39
SPIRIVA 76 64 41 61
ENALAPRIL MALEATE 75 75 42 34
ZOLPIDEM TARTRATE 75 74 42 23
FENTANYL 68 43 S2 44 45
DONEPEZIL HCL 65 65 45 30
DILTIAZEM ER 65 51 45 81
CIPROFLOXACIN HCL 64 58 47 60
PROAIR HFA 57 51 48 75
TRIAMTERENE-HYDROCHLOROTHIAZID 56 54 49 122
TRIAMCINOLONE ACETONIDE 56 56 49 102
CARBIDOPA-LEVODOPA 56 56 49 69
FLUOXETINE HCL 55 46 52 73
MELOXICAM 55 54 52 24
AMLODIPINE BESYLATE-BENAZEPRIL 53 53 54 80
BENAZEPRIL HCL 51 50 55 44
EVISTA 51 51 55 119
TRAZODONE HCL 51 45 55 51
IBUPROFEN 50 42 58 140
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 9, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.